Skip to main content
Frontiers in Oncology logoLink to Frontiers in Oncology
. 2021 Sep 7;11:747316. doi: 10.3389/fonc.2021.747316

Corrigendum: Prediction of EGFR Mutation Status Based on 18F-FDG PET/CT Imaging Using Deep Learning-Based Model in Lung Adenocarcinoma

Guotao Yin 1,, Ziyang Wang 1,, Yingchao Song 2,, Xiaofeng Li 1, Yiwen Chen 1, Lei Zhu 1, Qian Su 1, Dong Dai 1,*, Wengui Xu 1,*
PMCID: PMC8453350  PMID: 34557420

In the original article, there was a mistake in Table 2 as published. The clinical model was changed in the process of revising the manuscript. Due to our negligence, the AUC, sensitivity, and specificity of the clinical model for the training dataset were not correctly revised. The corrected Table 2 appears below.

Table 2.

Predictive performance of different models in the training dataset.

AUC (95% CI) Sensitivity (%) Specificity (%) Accuracy (%)
StackPET-CT 0.86 (0.80-0.91) 71.75 84.38 75.25
 SECT 0.74 (0.67-0.80) 82.35 53.12 67.17
 SEPET 0.75 (0.69-0.81) 86.25 56.25 72.22
Clinical model 0.63 (0.55-0.69) 50.98 71.88 60.10

The bold values represented the highest one of the evaluation indices.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.


Articles from Frontiers in Oncology are provided here courtesy of Frontiers Media SA

RESOURCES